HIK — Hikma Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Hikma Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	465	347	450	292	229
Net Total Accounts Receivable
Net Total Receivables	749	734	876	841	873
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,848	1,922	2,094	1,999	2,100
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	962	1,068	1,146	1,081	1,141
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,930	4,135	4,372	4,471	4,680
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,471	1,028	1,016	1,077	1,339
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,813	2,000	1,919	2,336	2,482
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,117	2,135	2,453	2,135	2,198
Total Liabilities & Shareholders' Equity	3,930	4,135	4,372	4,471	4,680
Total Common Shares Outstanding